NCT00618254 A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fasting Conditions Status COMPLETED Phase NA
NCT00618111 A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fed Conditions Status COMPLETED Phase NA
NCT00550251 Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients? Formal Study Status UNKNOWN Phase NA
NCT00537875 Evaluation of the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens Status COMPLETED Phase NA
NCT00503386 Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting Status COMPLETED Phase PHASE2
NCT00452972 Exteriorized Versus In Situ Uterine Repair at Cesarean Delivery Status COMPLETED Phase NA
NCT00452855 Sevoflurane-Remifentanil Anaesthesia. The Risk of Post Operative Nausea Status COMPLETED Phase NA
NCT00450853 Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer Patients Status COMPLETED Phase PHASE2
NCT00445055 Evaluation of 2 Doses of Intravenous Droperidol in the Prevention of Postoperative Nausea Status TERMINATED Phase PHASE4
NCT00432991 Study of the Effect of Intramuscular Ephedrine on the Incidence of Nausea and Vomiting During Elective Cesarean Section Status COMPLETED Phase PHASE2
NCT00429832 A RCT of Ondansetron and Promethazine in the Treatment of Nausea and Vomiting in the Emergency Department Status COMPLETED Phase PHASE4
NCT00429754 Pharmacokinetic Study of Aprepitant in BEP Treatment of Patients With Testis Carcinoma (A-BEP) Status WITHDRAWN Phase PHASE4
NCT00429702 Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy Status TERMINATED Phase PHASE2
NCT00410488 Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI) Status COMPLETED Phase NA
NCT00394966 A Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Study P04351AM2)(COMPLETED) Status COMPLETED Phase PHASE2
NCT00366834 Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting Status COMPLETED Phase PHASE3
NCT00359177 Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment Status COMPLETED Phase PHASE1
NCT00358813 Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment Status COMPLETED Phase PHASE1